Inhibition by acetaminophen of neoplastic initiation elicited in rat liver by the DNA-reactive hepatocarcinogen N-acetyl-2-aminofluorene

European Journal of Cancer Prevention

Volumn 16, Issue 6, 2007, Pages 528-534

  Williams, Gary M ^a   Iatropoulos, Michael J ^a   Jeffrey, Alan M ^a   Duan, Jian Dong ^a   Perrone, Carmen E ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Analgesic; Aromatic amine; Chemoprevention; Liver

Indexed keywords

CARCINOGEN; CYCLINE; DNA; GLUTATHIONE TRANSFERASE P1; N (2 FLUORENYL)ACETAMIDE; NUCLEOTIDE; PARACETAMOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL PROTECTION; CHEMICAL LABELING; CONTROLLED STUDY; DNA ADDUCT; DRUG BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LIGHT DARK CYCLE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER PROTECTION; MALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT DURATION; TREATMENT OUTCOME;

2-ACETYLAMINOFLUORENE; ACETAMINOPHEN; ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; LIVER; LIVER NEOPLASMS; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344;

EID: 37349033857     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000243854.12728.b8     Document Type: Article

References (39)

1. Colin P, Sirois G, Chakzabarti S (1987). Rapid high-performance liquid chromatographic assay of acetaminophen in serum and tissue homogenates. J Chromatogr 413:151-160.
2. Cramer DW, Harlow BL, Titus-Ernstoff L, Bohlke K, Welch WR, Greenberg ER (1998). Over-the-counter analgesics and risk of ovarian cancer. Lancet 351:104-107.
3. Dietrich DR (1993). Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit Rev Toxicol 23:77-109.
4. Dunnett CW (1955). A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50:1096-1121.
5. Gangl ET, Turesky RJ, Vouros P (2001). Detection of in vivo formed DNA adducts at the part-per-billion level by capillary liquid chromatograph/ microelectrospray mass spectrometry. Anal Chem 73:2397-2404.
6. 32P-postlabeling analysis of aromatic carcinogen-DNA adducts. Cancer Res 45:5656-5662.
7. Hasegawa R, Furukawa F, Toyoda K, Jang JJ, Yamashita K, Sato S, et al. (1988). Study for tumor-initiating effect of acetaminophen in two-stage liver carcinogenesis of male F344 rats. Carcinogenesis 9:755-759.
8. Iatropoulos MJ, Williams GM (1996). Proliferation markers. Exp Toxicol Pathol 48:175-181.
9. Jeffrey AM, Jennette KW, Blobstein SH, Weinstein IB, Beland FA, Harvey RG, et al. (1976). Benzo[a]pyrene-nucleic acid derivative found in vivo: structure of benzo[a]pyrene tetrahydrodiol epoxide-guanosine adduct. J Am Chem Soc 98:5714-5715.
10. Jeffrey AM, Luo FQ, Amin S, Krzeminski J, Zech K, Williams GM (2002). Lack of DNA binding in the rat nasal mucosa and other tissues of the nasal toxicants roflumilast, a phosphodiesterase 4 inhibitor, and a metabolite, 4-amino-3,5-dichloropyridine, in contrast to the nasal carcinogen 2,6-dimethylaniline. Drug Chem Toxicol 25:93-107.
11. Leong CO, Gaskell M, Martin EA, Heydon RT, Farmer PB, Bibby MC, et al. (2003). Antitumour 2-(4-aminophenyl)benzothiasoles generate DNA adducts in sensitive tumour cells in vitro and in vivo. Br J Cancer 88:470-477.
12. Muscat JE, Stellman SD, Wynder EL (1995). Analgesic use and colorectal cancer. Prev Med 24:110-112.
13. Phillips DH, Castegnaro M (1999). Standardization and validation of DNA adduct postlabeling methods: report of interlaboratory trials and production of recommended protocols. Mutagenesis 14:301-315.
14. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7:1543-1551.
15. Rogers LK, Moorthy B, Smith CV (1997). Acetaminophen binds to mouse hepatic and renal DNA at human therapeutic doses. Chem Res Toxicol 10:470-476.
16. Sato K (1989). Glutathione transferases as markers of preneoplasia and neoplasia. Adv Cancer Res 52:205-225.
17. Schmeiser HH, Bieler CA, Wiessler M, Fried M, Erdinger L (1999). Identification of specific DNA-adduct patterns in organic chemical structures in outdoor air [in German]. http://bwplus.fzk.de/berichte/ZBer/99/ZBerL96011.pdf. 1-12.
18. Shen L, Qiu S, Chen Y, Zhang F, van Breemen RB, Nikolic D, Bolton JL (1998). Alkylation of 2′-deoxynucleosides and DNA by the premarin metabolite 4-hydroxyequilenin semiquinone radical. Chem Res Toxicol 11:94-101.
19. Tanaka T, Mori H, Hirota N, Furuya K, Williams GM (1986). Effect of DNA synthesis on induction of preneoplastic and neoplastic lesions in rat liver by a single dose of methylazoxymethanol acetate. Chem Bio Interactions 58:13-27.
20. Tong C, Fazio M, Williams GM (1980). Cell cycle-specific mutagenesis at the hypoxanthine phosphoribosyl-transferase locus in adult rat liver epithelial cells. Proc Natl Acad Sci USA 77:7377-7379.
21. Turesky RJ, Markovic J (1994). DNA adduct formation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline at the C-8 and N2 atoms of guanine. Chem Res Toxicol 7:752-761.
22. Umemura T, Tokumo K, Gebhardt R, Poirier M, Williams GM (1993). Dose-response effects of 2-acetylaminofluorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver. Cancer Lett 73:1-10.
23. 2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in vivo. Chem Res Toxicol 13:1165-1173.
24. Weisburger JH, Weisburger EK (1973). Biochemical formation and pharmacological, toxicological and pathological properties of hydroxylamines and hydroxamic acids. Pharmacol Res 25:1-66.
25. Williams GM (1980). The pathogenesis of rat liver cancer caused by chemical carcinogens. Biochim Biophys Acta 605:167-189.
26. Williams GM (1982). Phenotypic properties of preneoplastic rat liver lesions and applications to detection of carcinogens and tumor promoters. Toxicol Pathol 10:3-10.
27. Williams GM (1999). Chemically induced preneoplastic lesions in rodents as indicators of carcinogenic activity. In: McGregor DB, Rice JM, Venitt S, editors. The use of short- and medium-term tests for carcinogens and data on genetic effects in carcinogenic hazard evaluation. Lyon, France: IARC. pp. 185-202.
28. Williams GM (2001). Mechanisms of chemical carcinogenesis and application to human cancer risk assessment. Toxicology 166:3-10.
29. Williams GM, Watanabe K (1978). Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen. J Natl Cancer Inst 61:113-121.
30. 1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxy toluene. Cancer Lett 104:49-53.
31. Williams GM, Iatropoulos MJ (1997). Inhibition by acetaminophen of intestinal cancer in rats induced by an aromatic amine similar to food mutagens. Eur J Cancer Prev 6:357-362.
32. Williams GM, Tanaka T, Maruyama H, Maeura Y, Weisburger JH, Zang E (1991). Modulation by butylated hydroxytoluene of liver and bladder carcinogenesis induced by chronic low-level exposure to 2-acetylaminofluorene. Cancer Res 51:6224-6230.
33. Williams GM, Iatropoulos MJ, Wang CX, Jeffrey AM, Thompson S, Pittman B, et al. (1998). Nonlinearities in 2-acetylaminofluorene exposure responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver. Toxicol Sci 45:152-161.
34. Williams GM, Iatropoulos MJ, Jeffrey AM (2000). Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine. Toxicol Pathol 28:88-95.
35. Williams GM, Iatropoulos MJ, Jeffrey AM, Shirai T (2002a). Protective effect of acetaminophen against colon cancer initiation effects of 3,2′-dimethyl-4-aminobiphenyl in rats. Eur J Cancer Prev 11:39-48.
36. Williams GM, Iatropoulos MJ, Jeffrey AM (2002b). Anticarcinogenicity of monocyclic phenolic compounds. Eur J Cancer Prev 11:S101-S107.
37. Williams GM, Iatropoulos MJ, Jeffrey AM (2004). Thresholds for the effects of 2-acetylaminofluorene in rat liver. Toxicol Pathol 32 (Suppl 2):246-252.
38. Yamamoto RS, Williams GM, Richardson HL, Weisburger EK, Weisburger JH (1973). Effect of p-hydroxyacetanilide on liver cancer induction by N-hydroxy-N-2-fluorenylacetamide. Cancer Res 33:454-457.
39. Zhao X, Demary K, Wong L, Vaziri C, McKenzie AB, Eberlein TJ, Spanjaard RA (2001). Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN). Cell Death Differ 8:878-886.